RT @cardiomet_CE: 10b) Given that ⬇️ing #LDL-C with proven agents ⬇️ #CVD risk, pts at high CVD risk w/ #obesity & #hypercholesterolemia ma…
10b) Given that ⬇️ing #LDL-C with proven agents ⬇️ #CVD risk, pts at high CVD risk w/ #obesity & #hypercholesterolemia may benefit from a dual approach of interventions that promote both ⬇️in LDL-C & weight ⬇️. See 🔓 https://t.co/3GCiFUI0bO 🔓 https
Thank you for sticking around till the end. There are books written on HLD but I hope this brief tweetorial was helpful to new/ future PGY-1s. To learn about more things Cardiology, check us out @CardiologyUniv . to learn more: https://t.co/2XZEZCdP5g 📜
RT @nationallipid: Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-societ…
RT @nationallipid: Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-societ…
RT @nationallipid: Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-societ…
Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-society Guideline on Blood Cholesterol Management. #Cardiology #CholesterolGuidelines #CholesterolEducationMonth https://t.co/JecJi1Hbzf https
Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-society Guideline on Blood Cholesterol Management. #Cardiology #CholesterolGuidelines #CholesterolEducationMonth https://t.co/JecJi1Hbzf https
AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines 2018 https://t.co/hil4AY5g2b
RT @DrNadolsky: @kevinnbass @hjluks Read how they are put together https://t.co/C4JnStcaHk
@kevinnbass @hjluks Read how they are put together https://t.co/C4JnStcaHk
ステロイドとか飲んでるし 脂質異常症の学び直しと軽い気持ちで論文読み始めたら 半日経過😅 血中コレステロールの管理に関するガイドライン PMID: 30423393 https://t.co/cO5SkMiumC 4.5.5 慢性炎症性疾患とHIVの成人
@bbculp @JWLevitt @ACShilton @YoniFreedhoff That post focuses more on public health reasoning: If patients don't do it & don't return fasted, it doesn't get done. Though ACC's guidelines also show generally that the difference in fasting/nonfasting lev
RT @ACCinTouch: Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddle…
RT @ACCinTouch: Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddle…
RT @ACCinTouch: Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddle…
RT @ACCinTouch: Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddle…
RT @ACCinTouch: Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddle…
RT @ACCinTouch: Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddle…
Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddleEast 2021 Hybrid education sessions are underway this morning! Her top takeaway slide 👇 https://t.co/3u7JgJ7KOE @JACCJournals #ACCInt
@DBelardoMD @APoisonedApple When I search "lipid" under the Guidelines search function at https://t.co/WEqE1m0L7J, I get multiple hits. I believe you are referring to the 2018 Guidelines at: https://t.co/49e6jccrcq
Most healthy adults not on statins don't have to take a fasted blood test for accuracy. https://t.co/xhCTwsPSjy
@Karageorgos15 2018 multisoc recs label LDL-C ≥190 mg/dL as severe hypercholesterolemia. See pgs e300-1 of below link. This reflects the idea that those w highest baseline LDL-C (∴ most absolute ⬇️LDL-C w lipid-lowering tx) will in general achieve the grea
@zadigbarcelo @docisa33 Tout à fait, des recommandations avec un niveau de preuve particulièrement faible et entachées de conflits d'intérêt. Mieux vaut se tourner vers les recommandations américaines de l'AHA/ACC qui sont plus scientifiques: https://t.co/
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
RT @DrMAlAteeq: 2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guid…
2️⃣ Dyslipidemia Guidelines from AHA/ACC (2018) https://t.co/f6VEiyDz0r Primary Prevention of Cardiovascular Disease Guidelines from ACC/AHA (2019) https://t.co/u8XU6Z4kZ7 BA guidelines from GINA (2020) https://t.co/rwd8iD7ZWv
RT @skathire: Several common clinical questions to discuss based on this patient. The patient's lipid profile was non-fasting. Should I g…
Several common clinical questions to discuss based on this patient. The patient's lipid profile was non-fasting. Should I get a fasting one? Generally, *NO*. Get lipid fasting panel only if TG > 400 mg/dl See below from US guidelines. https://t.
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline Management of Blood Cholesterol: Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines - ScienceDirect https://t.co/MK4v9ENl
RT @Lipidologist: Absence of coronary artery calcium does not rule out noncalcified plaque. Even w/ 0 CACS, pts may still have substantial…
RT @Lipidologist: Absence of coronary artery calcium does not rule out noncalcified plaque. Even w/ 0 CACS, pts may still have substantial…
RT @Lipidologist: Absence of coronary artery calcium does not rule out noncalcified plaque. Even w/ 0 CACS, pts may still have substantial…
RT @Lipidologist: Absence of coronary artery calcium does not rule out noncalcified plaque. Even w/ 0 CACS, pts may still have substantial…
RT @Lipidologist: Absence of coronary artery calcium does not rule out noncalcified plaque. Even w/ 0 CACS, pts may still have substantial…
RT @Lipidologist: Absence of coronary artery calcium does not rule out noncalcified plaque. Even w/ 0 CACS, pts may still have substantial…
Agree, especially with younger patients that may have significant non calcified plaque.
RT @Lipidologist: Absence of coronary artery calcium does not rule out noncalcified plaque. Even w/ 0 CACS, pts may still have substantial…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
RT @DavidWienerMD: @cardiojaydoc02 @DrToniyaSingh Best use for coronary calcium scoring is decision about statin therapy: https://t.co/l9UO…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
RT @Doc_Tiger: And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asympto…
And just a reminder, medical therapy can provide pretty impressive plaque regression so that should be first line in asymptomatic @Heart_SCCT @journalCCT #jcct #yesCCT https://t.co/LPL060k5Jj https://t.co/zXt0Ptr7R8
Totally agree with this comment. CCS is for guiding primary prevention in asymptomatic...not to prompt invasive treatment... a non-evidenced-based Pandora’s box 📦
RT @DavidWienerMD: @cardiojaydoc02 @DrToniyaSingh Best use for coronary calcium scoring is decision about statin therapy: https://t.co/l9UO…
RT @DavidWienerMD: @cardiojaydoc02 @DrToniyaSingh Best use for coronary calcium scoring is decision about statin therapy: https://t.co/l9UO…
@cardiojaydoc02 @DrToniyaSingh Best use for coronary calcium scoring is decision about statin therapy: https://t.co/l9UOdcGH0j. Reflex stress test of asymptomatic, high functioning people just based on CCS sends us down this 🐰 hole. #BeAClinician
@Pirulla25 Gordura não é bom Pirulla, segue o guideline da American Heart Association sobre o manejo dos níveis de colesterol. Na página 16 está falando sobre dieta. Segue na fontes que vai estar falando de dieta. https://t.co/RZwyZ3x40P Quem fala que gor
Guidelines. Yay. Let's see what's in for #CvPrev https://t.co/gpUGJhBlWz
https://t.co/wc2xUv5JVp Guideline on the Management of Blood Cholesterol 2018 @AJeunesMedVasc @zudenstein @TristanMirault @AboyansV https://t.co/d6GsKhbyfz
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline... https://t.co/TOl0fe5ULf
#Must_Read Top Ten Things Every Clinician Should Know About the 2018 Cholesterol Guidelines 2018 Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology https://t.co/rHvdP8APkj @accpcardprn @pharmacists @ASHPOf
Full guidelines here: https://t.co/wUKyY7ic9l
RT @JACCJournals: First U.S. Guideline in five years on Management of Blood Cholesterol is now live, with guidance on newer agents & shared…
RT @Links_Medicus: Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guidel…
@ZainabSG1 حساب LDL يتم عن طريق معادلة فردوالد ويتأثر بالمستويات العالية من الدهون الثلاثية التي تزيد غالباً في العينات غير الصائمة الدليل كامل : https://t.co/eOrlSmp6yz
RT @Links_Medicus: Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guidel…
RT @Links_Medicus: Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guidel…
RT @Links_Medicus: Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guidel…
RT @Links_Medicus: Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guidel…
RT @Links_Medicus: Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guidel…
RT @Links_Medicus: Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guidel…
RT @Links_Medicus: Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guidel…
RT @Links_Medicus: Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guidel…
Clinical Guideline Synopsis: Management of Blood Cholesterol https://t.co/8pVvst3rtc via @JAMA_current Original Guideline: https://t.co/VcH4T37ps6 Editorial: https://t.co/hyY3Gdt3Jj
RT @AmbrizMau: La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo:…
RT @AmbrizMau: La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo:…
RT @AmbrizMau: La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo:…
RT @AmbrizMau: La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo:…
La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo: -IMC ≥30 -Glucosa en ayunas ≥100 mg/dl -Síndrome metabólico -Hemoglobina glucosilada ≥6% J Am Coll Cardiol 2018;doi: https://t.co/
For those who missed it, the 2018 AHA/ACC Cholesterol Management guidelines came out recently. This is the algorithm for patients with clinical ASCVD. https://t.co/Ut1FCUA4SO https://t.co/OJoVYKGgTr
RT @IllinoisACC: New 2018 Guidelines on the Management of Blood Cholesterol in @JACCJournals! @ACC @AHA Full Guidelines: https://t.co/ufj3O…
RT @IllinoisACC: New 2018 Guidelines on the Management of Blood Cholesterol in @JACCJournals! @ACC @AHA Full Guidelines: https://t.co/ufj3O…
RT @IllinoisACC: New 2018 Guidelines on the Management of Blood Cholesterol in @JACCJournals! @ACC @AHA Full Guidelines: https://t.co/ufj3O…
RT @SEHLELHA140_90: Ya disponible Nuevas Guías #AHA18 sobre colesterol https://t.co/pM2TsZLsMq @TGijonConde @ManuelGorostidi @16pacomoral…
RT @JACCJournals: First U.S. Guideline in five years on Management of Blood Cholesterol is now live, with guidance on newer agents & shared…